Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07451197 · ClinicalTrials.gov registry record · NA
Family-Focused Study to Support Medication for Opioid Use Disorder
A NA study, sponsored by University of Wisconsin, Madison.
- Not yet
- Registry status
- NA
- Development phase
- 338
- Enrollment target
NCT07451197: Clinical Trial NA study, sponsored by University of Wisconsin, Madison.
NCT07451197 is a NA study that has not yet begun recruiting, run by University of Wisconsin, Madison. The registered enrollment target is 338 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07451197, a NA study, has not yet begun recruiting, sponsored by University of Wisconsin, Madison.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 338 participants
- Enrollment target
Study Summary
The purpose of this clinical trial is to develop and test whether a text- and web-based tool called FamilyCHESS - designed for individuals with opioid use disorder (OUD) and a concerned significant other (CSO) - can help the identified patient (IP) begin and stay on medication for opioid use disorder (MOUD).
Primary Outcome
Number of days between study start date and MOUD initiation date.
Interventions
- BEHAVIORAL Standard of Care
- BEHAVIORAL FamilyCHESS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 338 participants |
| Start Date | 2027-08-31 |
| Est. Completion | 2031-08-31 |
| Phase | NA |
What is known before NCT07451197 opens enrollment
NCT07451197 is an interventional study that assigns participants to a tested intervention. The registered 338 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower).
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT07451197 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07451197 about?
NCT07451197 is a clinical study titled "Family-Focused Study to Support Medication for Opioid Use Disorder". The purpose of this clinical trial is to develop and test whether a text- and web-based tool called FamilyCHESS - designed for individuals with opioid use disorder (OUD) and a concerned significant other (CSO) - can help the identified patient (IP) begin and stay on medication for opioid use disorde...
What is the current status of trial NCT07451197?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 338 participants. The study started on 2027-08-31. Estimated completion is 2031-08-31.
What interventions are being tested in trial NCT07451197?
The interventions under investigation include: Standard of Care (BEHAVIORAL), FamilyCHESS (BEHAVIORAL).
Who is sponsoring clinical trial NCT07451197?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07451197's enrollment target sits among peer trials
338 305th of 2000 higher than 1,696 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03253263 · 338 participants · Phase 2
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
- NCT05658731 · 338 participants · NA
Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients
- NCT06022939 · 338 participants · Phase 3
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
- NCT04176172 · 340 participants · Phase 3
Optimizing Tobacco Use Treatment for PLWHA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI